Raymond James Financial
JAZZ icon

Raymond James Financial’s Jazz Pharmaceuticals JAZZ Stock Holding History

Raymond James Financial’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.1M Buy
228,645
+44,181
+24% +$9.68M 0.01% 886
2026
Q1 		$34.6M Buy
184,464
+7,128
+4% +$1.25M 0.01% 1089
2025
Q4 		$30.2M Buy
177,336
+18,470
+12% +$2.83M 0.01% 1161
2025
Q3 		$20.9M Sell
158,866
-116
-0.1% -$13.9K 0.01% 1380
2025
Q2 		$16.9M Buy
158,982
+3,916
+3% +$425K 0.01% 1492
2025
Q1 		$19.3M Buy
155,066
+62,719
+68% +$8.18M 0.01% 1343
2024
Q4 		$11.4M Buy
+92,347
New +$10.9M ﹤0.01% 1743

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Raymond James Financial's JAZZ Position: Q2 2026 in Review

Raymond James Financial increased its Jazz Pharmaceuticals (JAZZ) stake by 24% in Q2 2026, buying an estimated $9.68M and bringing the position to 228,645 shares worth $55.1M. The position accounts for 0.01% of the portfolio, ranked #886.

Raymond James Financial first reported a position in JAZZ in Q4 2024 and has held it in 7 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Raymond James Financial held 228,645 shares of Jazz Pharmaceuticals worth $55.1M as of Q2 2026.
  • Raymond James Financial bought 44,181 Jazz Pharmaceuticals shares in Q2 2026, an estimated $9.68M.
  • Jazz Pharmaceuticals made up 0.01% of Raymond James Financial's portfolio in Q2 2026, its #886 holding.
  • Raymond James Financial first reported a position in Jazz Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.